510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K061492Substantially Equivalent

Monoject Magellan Insulin and Tuberculin Safety Syringe

Tyco Healthcare, Mansfield MA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K061492 is the FDA 510(k) clearance record for MONOJECT MAGELLAN INSULIN AND TUBERCULIN SAFETY SYRINGE, a class II device, cleared for Tyco Healthcare on under FDA product code FMF (Syringe, Piston). FDA records list 14 510(k) clearances for Tyco Healthcare, from to . As of , FDA records show no recalls naming K061492.

Clearance record

Decision date
Received
(64 days to decision)
Product code
FMF Syringe, Piston
Regulation
21 CFR 880.5860
Device class
Class II
Review panel
General Hospital
Applicant
Tyco Healthcare 15 Hampshire St., Mansfield MA
510(k) summary
Summary PDF
Third party review
No

Clearances, product code FMF

Trailing 12 months
14 clearances under product code FMF in the twelve months to October 2026, December 2025 the highest month at 4.
Show the numbers
Monthly 510(k) clearances under FDA product code FMF, trailing twelve months
MonthClearances
November 20251
December 20254
January 20260
February 20261
March 20260
April 20261
May 20261
June 20262
July 20261
August 20263
September 20260
October 20260